January, 10 2021, 11:00pm EDT
Delays on Biden's Secretary of State Nominee Put National Security At Risk
Reports show Blinken’s nomination has been stalled by Senate Republicans in Committee “It is unacceptable that Senate Republicans wasted valuable time dragging their feet on Antony Blinken’s nomination, putting our national security at risk”
WASHINGTON
Today, reporting revealed that delays in the Senate make it unlikely that President-elect Biden's nominee for secretary of state, Antony Blinken, will have a confirmation hearing before Inauguration Day. This would be the first time in 10 transitions of power that the incoming president's pick for State wouldn't have a hearing or have already been confirmed prior to January 20th. Blinken was one of President-elect Biden's first Cabinet picks on November 24, 2020. According to reports, Blinken completed paperwork on December 31, but his nomination has stalled as Senate Republicans worked to obstruct a speedy confirmation process. By contrast, President Trump's pick for secretary of State, Rex Tillerson, came before the Senate Foreign Relations Committee on January 11, 2017, and President Obama's first pick for the department, Hillary Clinton, had her hearing on January 13, 2009.
Since President-elect Biden's victory, President Trump and his allies in the Senate have done everything in their power to block a smooth transition to the next administration -- including on matters of national security -- and to slow-walk the confirmation process for Biden's nominees. Senate Republicans have known since the election that they were going to maintain control of the Senate during the transition period, meaning the delays for Blinken and other national security nominees lay squarely at their feet. Earlier today, the Accountable Senate War Room released an in-depth memo outlining how, with less than two weeks until Inauguration Day, Senate Republicans are already dramatically behind on the Cabinet nomination process and why these delays put Americans' national security and public health interests at an even greater risk.
"It is unacceptable that Senate Republicans wasted valuable time dragging their feet on Antony Blinken's nomination, effectively putting our national security at risk when President-elect Biden takes office in nine days," said Mairead Lynn, spokesperson for the Accountable Senate War Room. "It is time for Senate Republicans to stop slow-walking Blinken's nomination and get to work advancing the President-elect's steady, competent choice for secretary of state."
Read more in Accountable Senate War Room's MEMO
Watchdog group Accountable.US recently launched the Accountable Senate War Room to fight back against those lawmakers who seek to overturn the will of the people by standing in the way of the smooth transition of power and the swift approval of nominees to ensure that the government can function and deliver results for the American people.
Accountable.US is a nonpartisan watchdog that exposes corruption in public life and holds government officials and corporate special interests accountable by bringing their influence and misconduct to light. In doing so, we make way for policies that advance the interests of all Americans, not just the rich and powerful.
LATEST NEWS
'Heinrich Should Be Ashamed': Lone Senate Dem Helps GOP Deliver Big Pharma Win
The provision, part of the Senate budget bill, was described as "a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars."
Jul 01, 2025
The deep-pocketed and powerful pharmaceutical industry notched a significant victory on Monday when the Senate parliamentarian ruled that a bill described by critics as a handout to drug corporations can be included in the Republican reconciliation package, which could become law as soon as this week.
The legislation, titled the Optimizing Research Progress Hope and New (ORPHAN) Cures Act, would exempt drugs that treat more than one rare disease from Medicare's drug-price negotiation program, allowing pharmaceutical companies to charge exorbitant prices for life-saving medications in a purported effort to encourage innovation. (Medications developed to treat rare diseases are known as "orphan drugs.")
The consumer advocacy group Public Citizen observed that if the legislation were already in effect, Medicare "would have been barred from negotiating lower prices for important treatments like cancer drugs Imbruvica, Calquence, and Pomalyst."
Among the bill's leading supporters is Sen. Martin Heinrich (D-N.M.), whose spokesperson announced the parliamentarian's decision to allow the measure in the reconciliation package after previously advising that it be excluded. Heinrich is listed as the legislation's only co-sponsor in the Senate, alongside lead sponsor Sen. John Barrasso (R-Wyo.).
"Sen. Heinrich should be ashamed of prioritizing drug corporation profits over lower medicine prices for seniors and people with disabilities," Steve Knievel, access to medicines advocate at Public Citizen, said in a statement Monday. "Patients and consumers breathed a sigh of relief when the Senate parliamentarian stripped the proposal from Republicans' Big Ugly Betrayal, so it comes as a gut punch to hear that Sen. Heinrich welcomed the reversal and continued to champion a proposal that will transfer billions from taxpayers to Big Pharma."
"People across the country are demanding lower drug prices and for Medicare drug price negotiations to be expanded, not restricted," Knievel added. "Sen. Heinrich should apologize to his constituents and start listening to them instead of drug corporation lobbyists."
The Biotechnology Innovation Organization, a lobbying group whose members include pharmaceutical companies, has publicly endorsed and promoted the legislation, urging lawmakers to pass it "as soon as possible."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients."
The nonpartisan Congressional Budget Office has estimated that the ORPHAN Cures Act would cost U.S. taxpayers around $5 billion over the next decade.
Merith Basey, executive director of Patients For Affordable Drugs Now, said that "patients are infuriated to see the Senate cave to Big Pharma by reviving the ORPHAN Cures Act at the eleventh hour."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars," said Basey. "We call on lawmakers to remove this unnecessary provision immediately and stand with an overwhelming majority of Americans who want the Medicare Negotiation program to go further. Medicare negotiation will deliver huge savings for seniors and taxpayers; this bill would undermine that progress."
Keep ReadingShow Less
Trump-Musk Gutting of USAID Could Lead to More Than 14 Million Deaths Over Five Years: Study
"For many low and middle income countries, the resulting shock would be comparable in scale to a global pandemic or a major armed conflict," said the coordinator behind the study.
Jul 01, 2025
A study published Monday by the medical journal The Lancet found that deep funding cuts to the U.S. Agency for International Development, a main target of the Department of Government Efficiency's government-slashing efforts, could result in more than 14 million additional deaths by the year 2030.
For months, humanitarian programs and experts have sounded the alarm on the impact of cutting funding for the U.S. Agency for International Development (USAID), which is the largest funding agency for humanitarian and development aid around the globe, according to the study.
"Our analysis shows that USAID funding has been an essential force in saving lives and improving health outcomes in some of the world's most vulnerable regions over the past two decades," said Daniella Cavalcanti, postdoctoral researcher at the Institute of Collective Health and an author of the study, according to a statement published Tuesday. Between 2001 and 2021, an estimated 91 million deaths were prevented in low and middle income countries thanks programs supported by USAID, according to the study.
The study was coordinated by researchers from the Barcelona Institute for Global Health with the help of the Institute of Collective Health of the Federal University of Bahia, the University of California Los Angeles, and the Manhiça Centre for Health Research, as well as others.
To project the future consequences of USAID funding cuts and arrive at the 14 million figure, the researchers used forecasting models to simulate the impact of two scenarios, continuing USAID funding at 2023 levels versus implementing the reductions announced earlier this year, and then comparing the two.
Those estimated 14 million additional deaths include 4.5 million deaths among children younger than five, according to the researchers.
The journalist Jeff Jarvis shared reporting about the study and wrote "murder" on X on Tuesday.
In March, Secretary of State Marco Rubio announced that the 83% of the programs at USAID were being canceled. In the same post on X, he praised the Department of Government Efficiency, which at that point had already infiltrated the agency. "Thank you to DOGE and our hardworking staff who worked very long hours to achieve this overdue and historic reform," he wrote.
Davide Rasella, research professor at Barcelona Institute for Global Health and coordinator of the study, said in a statement Tuesday that "our projections indicate that these cuts could lead to a sharp increase in preventable deaths, particularly in the most fragile countries. They risk abruptly halting—and even reversing—two decades of progress in health among vulnerable populations. For many low- and middle-income countries, the resulting shock would be comparable in scale to a global pandemic or a major armed conflict."
One country where USAID cuts have had a particularly deadly impact is Sudan, according to The Washington Post, which reported on Monday that funding shortages have led to lack of medical supplies and food in the war-torn nation.
"There's a largely unspoken and growing death toll of non-American lives thanks to MAGA," wrote Ishaan Tharoor, a Post columnist, of the paper's reporting on Sudan.
In reference to the reporting on Sudan, others laid blame on billionaire Elon Musk, the billionaire and GOP mega-donor who was initially tapped to lead the Department of Government Efficiency.
"In a less imperfect world, Musk and [President Donald] Trump would be forever cast as killers of children, and this would be front-page news for months and the subject of Sunday sermons in every church," wrote the journalist David Corn.
Keep ReadingShow Less
GOP Still Lacks Votes to Pass Budget Bill 'Because It's a Moral Monstrosity,' Says Senate Democrat
"We have been debating amendments for 21 hours and we are still going because through 12 hours of debate and 21 hours of amendment votes, Republicans still don't have 50 votes for their bill," said Sen. Chris Murphy.
Jul 01, 2025
Even after an all-night session of amendment votes and wrangling behind closed doors, Senate Republicans still did not have enough support to pass their reconciliation package as of Tuesday morning, leaving party leaders scrambling to placate GOP holdovers who are purportedly nervous about the legislation's unprecedented cuts to Medicaid and federal nutrition assistance.
Sen. Chris Murphy (D-Conn.) argued in a social media post that the reason for the GOP's inability to quickly rally its own members around the legislation is straightforward: "Because it's a moral monstrosity."
"We have been debating amendments for 21 hours and we are still going because through 12 hours of debate and 21 hours of amendment votes, Republicans still don't have 50 votes for their bill," Murphy wrote at roughly 5:30 am ET, as the marathon "vote-a-rama" continued with no end in sight.
With Democrats unanimously opposed to the bill, Senate Republicans can only afford to lose three GOP votes if they are to send the measure back to the House for final approval. Sens. Rand Paul (R-Ky.) and Thom Tillis (R-N.C.) have said they will vote against the bill in its current form, and Sens. Lisa Murkowski (R-Alaska) and Susan Collins (R-Maine) are undecided. Sen. Ron Johnson (R-Wis.) also suggested he's on the fence.
Republican leaders have been working to bring Murkowski into the yes column with a proposal that would temporarily exempt Alaska and other states from the bill's massive cuts to the Supplemental Nutrition Assistance Program (SNAP). Sen. Amy Klobuchar (D-Minn.), the top Democrat on the Senate Agriculture Committee, ripped the proposal as "absurd" and said it would reward the states with the highest SNAP error rates.
"Insanity reigns," Klobuchar wrote on social media.
Senate Republicans' margins became more difficult after Sen. Thom Tillis (R-N.C.) announced his opposition to the legislation over the weekend, pointing to the Senate version's devastating cuts to Medicaid.
"What do I tell 663,000 people in two years or three years, when President Trump breaks his promise by pushing them off of Medicaid because the funding's not there anymore?" Tillis asked in a floor speech on Sunday, citing an estimate of the number of people in North Carolina who could lose health insurance under the Republican bill.
Throughout the country, nearly 12 million people would lose coverage under the Senate reconciliation bill, according to the nonpartisan Congressional Budget Office.
"Kicking millions off healthcare, blowing up the national debt by trillions, and devastating generational economic harms—all being written into law on the fly," Sen. Patty Murray (D-Wash.) said early Tuesday morning after hours of debate and amendment votes.
Keep ReadingShow Less
Most Popular